At InterveneRx, we want to keep you informed about the specialty drug industry.  Listed below are publications to help us do that:


13th Annual EMD Serono Specialty Digest™ Details Utilization and Clinical Management Trend
Yahoo News,May 1, 2017 


FDA Approvals for Specialty Drugs to pick up in 2017
Modern Medicine Network, March, 29, 2017 


Annual Medical Pharmacy Trend Report Illustrated Impact of Costly Specialty Drugs
Specialty Pharmacy Times, April 4, 2017 


Amgen’s PCSK9 inhibitor Repatha significantly cuts risk for cardiovascular events in outcomes study, but falls short of expectations.
First Word Pharma, March 21, 2017 


Harvard Pilgrim expands use of novel drug purchasing deals

Boston Globe, February 22, 2017; Priyanka Dayal McCluskey, Curt Woodward 


Plan Sponsors Zero in on Specialty Rx Costs, Retail 90 Networks in 2017 Benefits

AISHealth January 17, 2017; Reprinted from Drug Benefit News, Volume 17 Issue 21 November 4, 2016


Policy Recommendations to Promote Sustainable, Affordable Pricing for Specialty Pharmaceuticals, A National Business Group on Health Publiication, National Business Group on Health, Policy Brief, January 2017


Archimedes Specialty Drug Forecast:  2016-2020

Archimedes, LLC. November 2016